GSK Investigational Site

Hořovice 26831

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms

Studies at this site

• Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors — Running, not enrolling